Hes1 and Hes5 regulate vascular remodeling and arterial specification of endothelial cells in brain vascular development

Mechanisms of Development

Volumn 130, Issue 9-10, 2013, Pages 458-466

  Kitagawa, Masashi ^a,b   Hojo, Masato ^a   Imayoshi, Itaru ^b   Goto, Masanori ^a,b   Ando, Mitsushige ^a,b   Ohtsuka, Toshiyuki ^b   Kageyama, Ryoichiro ^b   Miyamoto, Susumu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Arterial specification; Brain vascular development; Hes1; Hes5; Notch; Vascular remodeling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; NOTCH RECEPTOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HES 5;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN DEVELOPMENT; CELL FATE; CEREBROVASCULAR MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE; HES1 GENE; HES5 GENE; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

MAMMALIA; MUS; VERTEBRATA;

EID: 84881548270     PISSN: 09254773     EISSN: 18726356     Source Type: Journal    
DOI: 10.1016/j.mod.2013.07.001     Document Type: Article

References (53)

1. Albig A.R., Becenti D.J., Roy T.G., Schiemann W.P. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvasc. Res. 2008, 76:7-14.
2. Alva J.A., Iruela-Arispe M.L. Notch signaling in vascular morphogenesis. Curr. Opin. Hematol. 2004, 11:278-283.
3. Carlson T.R., Yan Y., Wu X., Lam M.T., Tang G.L., Beverly L.J., Messina L.M., Capobianco A.J., Werb Z., Wang R. Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc. Natl. Acad. Sci. USA 2005, 102:9884-9889.
4. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000, 6:389-395.
5. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
6. Cau E., Gradwohl G., Casarosa S., Kageyama R., Guillemot F. Hes genes regulate sequential stages of neurogenesis in the olfactory epithelium. Development 2000, 127:2323-2332.
7. Chang L., Noseda M., Higginson M., Ly M., Patenaude A., Fuller M., Kyle A.H., Minchinton A.I., Puri M.C., Dumont D.J., Karsan A. Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling. Proc. Natl. Acad. Sci. USA 2012, 109:6993-6998.
8. Copeland J.N., Feng Y., Neradugomma N.K., Fields P.E., Vivian J.L. Notch signaling regulates remodeling and vessel diameter in the extraembryonic yolk sac. BMC Dev. Biol. 2011, 11:12.
9. Domenga V., Fardoux P., Lacombe P., Monet M., Maciazek J., Krebs L.T., Klonjkowski B., Berrou E., Mericskay M., Li Z., Tournier-Lasserve E., Gridley T., Joutel A. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 2004, 18:2730-2735.
10. Fischer A., Gessler M. Hey genes in cardiovascular development. Trends Cardiovasc. Med. 2003, 13:221-226.
11. Fischer A., Schumacher N., Maier M., Sendtner M., Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 2004, 18:901-911.
12. Gale N.W., Dominguez M.G., Noguera I., Pan L., Hughes V., Valenzuela D.M., Murphy A.J., Adams N.C., Lin H.C., Holash J., Thurston G., Yancopoulos G.D. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 2004, 101:15949-15954.
13. Gridley T. Notch signaling in vascular development and physiology. Development 2007, 134:2709-2718.
14. Guiu J., Shimizu R., D'Altri T., Fraser S.T., Hatakeyama J., Bresnick E.H., Kageyama R., Dzierzak E., Yamamoto M., Espinosa L., Bigas A. Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling. J. Exp. Med. 2013, 210:71-84.
15. Hashimoto N., Nozaki K., Takagi Y., Kikuta K., Mikuni N. Surgery of cerebral arteriovenous malformations. Neurosurgery 2007, 61:375-387. discussion 387-9.
16. Hatakeyama J., Bessho Y., Katoh K., Ookawara S., Fujioka M., Guillemot F., Kageyama R. Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation. Development 2004, 131:5539-5550.
17. Hatakeyama J., Sakamoto S., Kageyama R. Hes1 and Hes5 regulate the development of the cranial and spinal nerve systems. Dev. Neurosci. 2006, 28:92-101.
18. High F.A., Lu M.M., Pear W.S., Loomes K.M., Kaestner K.H., Epstein J.A. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. USA 2008, 105:1955-1959.
19. Hirata H., Tomita K., Bessho Y., Kageyama R. Hes1 and Hes3 regulate maintenance of the isthmic organizer and development of the mid/hindbrain. EMBO J. 2001, 20:4454-4466.
20. Hojo M., Kita A., Kageyama R., Hashimoto N. Notch-Hes signaling in pituitary development. Expert Rev. Endocrinol. Metab. 2008, 3:91-100.
21. Hojo M., Ohtsuka T., Hashimoto N., Gradwohl G., Guillemot F., Kageyama R. Glial cell fate specification modulated by the bHLH gene Hes5 in mouse retina. Development 2000, 127:2515-2522.
22. Imayoshi I., Sakamoto M., Yamaguchi M., Mori K., Kageyama R. Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. J. Neurosci. 2010, 30:3489-3498.
23. Imayoshi I., Shimogori T., Ohtsuka T., Kageyama R. Hes genes and neurogenin regulate non-neural versus neural fate specification in the dorsal telencephalic midline. Development 2008, 135:2531-2541.
24. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., Domenga V., Cecillion M., Marechal E., Maciazek J., Vayssiere C., Cruaud C., Cabanis E.A., Ruchoux M.M., Weissenbach J., Bach J.F., Bousser M.G., Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996, 383:707-710.
25. Kageyama R., Ohtsuka T., Hatakeyama J., Ohsawa R. Roles of bHLH genes in neural stem cell differentiation. Exp. Cell Res. 2005, 306:343-348.
26. Kageyama R., Ohtsuka T., Kobayashi T. The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development 2007, 134:1243-1251.
27. Kageyama R., Ohtsuka T., Kobayashi T. Roles of Hes genes in neural development. Dev. Growth Differ. 2008, 50(Suppl. 1):S97-S103.
28. Kageyama R., Ohtsuka T., Shimojo H., Imayoshi I. Dynamic Notch signaling in neural progenitor cells and a revised view of lateral inhibition. Nat. Neurosci. 2008, 11:1247-1251.
29. Kita A., Imayoshi I., Hojo M., Kitagawa M., Kokubu H., Ohsawa R., Ohtsuka T., Kageyama R., Hashimoto N. Hes1 and Hes5 control the progenitor pool, intermediate lobe specification, and posterior lobe formation in the pituitary development. Mol. Endocrinol. 2007, 21:1458-1466.
30. Kokubo H., Miyagawa-Tomita S., Nakazawa M., Saga Y., Johnson R.L. Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev Biol. 2005, 278:301-309.
31. Koni P.A., Joshi S.K., Temann U.A., Olson D., Burkly L., Flavell R.A. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 2001, 193:741-754.
32. Krebs L.T., Shutter J.R., Tanigaki K., Honjo T., Stark K.L., Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 2004, 18:2469-2473.
33. Krebs L.T., Starling C., Chervonsky A.V., Gridley T. Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants. Genesis 2010, 48:146-150.
34. Krebs L.T., Xue Y., Norton C.R., Shutter J.R., Maguire M., Sundberg J.P., Gallahan D., Closson V., Kitajewski J., Callahan R., Smith G.H., Stark K.L., Gridley T. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14:1343-1352.
35. Krebs L.T., Xue Y., Norton C.R., Sundberg J.P., Beatus P., Lendahl U., Joutel A., Gridley T. Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation. Genesis 2003, 37:139-143.
36. Li X., Zhang X., Leathers R., Makino A., Huang C., Parsa P., Macias J., Yuan J.X., Jamieson S.W., Thistlethwaite P.A. Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat. Med. 2009, 15:1289-1297.
37. Limbourg F.P., Takeshita K., Radtke F., Bronson R.T., Chin M.T., Liao J.K. Essential role of endothelial Notch1 in angiogenesis. Circulation 2005, 111:1826-1832.
38. Liu Z.J., Xiao M., Balint K., Soma A., Pinnix C.C., Capobianco A.J., Velazquez O.C., Herlyn M. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J. 2006, 20:1009-1011.
39. Morrow D., Cullen J.P., Cahill P.A., Redmond E.M. Cyclic strain regulates the Notch/CBF-1 signaling pathway in endothelial cells: role in angiogenic activity. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1289-1296.
40. Murphy P.A., Lam M.T., Wu X., Kim T.N., Vartanian S.M., Bollen A.W., Carlson T.R., Wang R.A. Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice. Proc. Natl. Acad. Sci. USA 2008, 105:10901-10906.
41. Murphy P.A., Lu G., Shiah S., Bollen A.W., Wang R.A. Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease. Lab. Invest. 2009, 89:971-982.
42. Ohtsuka T., Ishibashi M., Gradwohl G., Nakanishi S., Guillemot F., Kageyama R. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J. 1999, 18:2196-2207.
43. Quillard T., Coupel S., Coulon F., Fitau J., Chatelais M., Cuturi M.C., Chiffoleau E., Charreau B. Impaired Notch4 activity elicits endothelial cell activation and apoptosis: implication for transplant arteriosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2258-2265.
44. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
45. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999, 21:70-71.
46. Suchting S., Freitas C., le Noble F., Benedito R., Breant C., Duarte A., Eichmann A. The Notch ligand delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl. Acad. Sci. USA 2007, 104:3225-3230.
47. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
48. Takagi Y., Kikuta K., Sadamasa N., Nozaki K., Hashimoto N. Proliferative activity through extracellular signal-regulated kinase of smooth muscle cells in vascular walls of cerebral arteriovenous malformations. Neurosurgery 2006, 58:740-748. discussion 740-8.
49. Wang H.U., Chen Z.F., Anderson D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998, 93:741-753.
50. Winkler E.A., Bell R.D., Zlokovic B.V. Central nervous system pericytes in health and disease. Nat. Neurosci. 2011, 14:1398-1405.
51. Xin M., Small E.M., van Rooij E., Qi X., Richardson J.A., Srivastava D., Nakagawa O., Olson E.N. Essential roles of the bHLH transcription factor Hrt2 in repression of atrial gene expression and maintenance of postnatal cardiac function. Proc. Natl. Acad. Sci. USA 2007, 104:7975-7980.
52. Xue Y., Gao X., Lindsell C.E., Norton C.R., Chang B., Hicks C., Gendron-Maguire M., Rand E.B., Weinmaster G., Gridley T. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8:723-730.
53. ZhuGe Q., Zhong M., Zheng W., Yang G.Y., Mao X., Xie L., Chen G., Chen Y., Lawton M.T., Young W.L., Greenberg D.A., Jin K. Notch-1 signalling is activated in brain arteriovenous malformations in humans. Brain 2009, 132:3231-3241.